Antitumor activity of 5-substituted 2-acylamino-1,3,4-thiadiazoles against transplantable rodent tumors.
- 1 January 1985
- journal article
- research article
- Published by Pharmaceutical Society of Japan in CHEMICAL & PHARMACEUTICAL BULLETIN
- Vol. 33 (11) , 5126-5129
- https://doi.org/10.1248/cpb.33.5126
Abstract
The antitumor activities of twelve 2-N- and or 5-substituted 2-amino-1,3,4-thiadiazole analogs were tested on Lewis lung carcinoma in mice by intraperitoneal administration. 2-Amino-1,3,4-thiadiazole (ATDA), 2-formamido-1,3,4-thiadiazole and 2-trifluoroacetamido-1,3,4-thiadiazole significantly prolonged the life span of tumor bearing mice. 5-Substituted analogs and 2-urethane and 2-carbamate type compounds were inactive. 2-Formamido-1,3,4-thiadiazole showed more potent activity than the parent compound ATDA against P388, L1210 leukemia, B16 melanma and Lewis lung carcinoma. The differences in the antitumor activity among ATDA analogs are discussed.This publication has 7 references indexed in Scilit:
- Antitumor activity of 2-acylamino-1,3,4-thiadiazoles and related compounds.CHEMICAL & PHARMACEUTICAL BULLETIN, 1982
- Antileukemic activity of substituted ureidothiazoles, ureidothiadiazoles, and related compoundsJournal of Medicinal Chemistry, 1979
- Syntheses of the Amides Derived from Heterocyclic Acids and Heterocyclic Amines and Their Antitumor ActivitiesYAKUGAKU ZASSHI, 1976
- BIOCHEMISTRY AND PHARMACOLOGY OF PURINE ANALOGUES1967
- POTENTIATION OF ANTI-LEUKEMIC EFFECTS OF 2-AMINOTHIADIAZOLE BY ISONICOTINAMIDE + DERIVATIVES1964
- THE ANTILEUKEMIC ACTION OF 2 THIADIAZOLE DERIVATIVES1960
- EFFECTS OF NICOTINAMIDE AND RELATED COMPOUNDS ON THE ANTILEUKEMIC ACTIVITY OF 2-AMINO-1,3,4-THIADIAZOLE1960